Psychosis in Borrelia burgdorferi infection - part II: case reports.

Psychosis in Borrelia burgdorferi infection - part II: case reports. Psychiatr Pol. 2019 Jun 30;53(3):641-653 Authors: Brodziński S, Nasierowski T Abstract In the second part of the article case reports of three patients were presented. All patientswere treated for Borrelia infection and all of them developed psychotic disorders. History of each patient was different, as well as the probability of causal relationship between neuroborreliosis and psychosis. The first case concerns a female patient with no former psychiatric history, who developed psychotic episode secondary to neuroborreliosis. Psychotic disorders resolved after antibiotic treatment. In the second case, a male patient was previously twice hospitalized in psychiatric ward due to psychosis. During the third psychiatric hospitalization suspicion of Lyme neuroborreliosis (LNB) was propounded. Patient's health state improved after combined therapy with antibiotics and antipsychotic drugs. Direct causal relationship between neuroborreliosis and psychosis is ambiguous. The third case concerns a male patient who was initially treated for LNB and tick-borne encephalitis in an infectious diseases ward. During the hospitalization he developed the first in life episode of mania with psychotic features. Second episode of psychosis occurred after a tick bite and a vaccination against tick-borne encephalitis. In this case, coexistence of many diverse factors results in many difficulties in estimating of...
Source: Psychiatria Polska - Category: Psychiatry Tags: Psychiatr Pol Source Type: research

Related Links:

(CNN) — After more than three months of shutdowns, mandatory quarantines, self-imposed exile from society and working from home, nature-lovers looking for a well-earned breath of fresh air could face a possible collision course between coronavirus and tick-borne illnesses this summer. A “perfect storm,” warns Eva Sapi, a University of New Haven biology professor and group director for the Lyme Disease Research Group. Noting the mild winter on the East Coast, Sapi says, “We do have a bad year for the ticks.” Hikers, campers and anyone else eager for an escape could “just explode into...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Seen On WBZ-TV Syndicated CBSN Boston CNN LYME DISEASE tick season ticks Source Type: news
Three pending Bay Area biotech IPOs and follow-on offerings from four other drug makers could collectively raise more than $1.1 billion, highlighting biotech's latest Wall Street resurgence amid hope for new cancer treatments and drugs and vaccines targeting Covid-19. Annexon Inc., which said last week that it raised $100 million, marked its place for an initial public offering of $100 million filing as Nurix Therapeutics Inc. declared its intentions for a $100 million IPO and Nkarta Inc. detailed…
Source: Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Publication date: Available online 5 July 2020Source: The Veterinary JournalAuthor(s): A.L. Hatke, D.R. Green, K. Stasiak, R.T. Marconi
Source: The Veterinary Journal - Category: Veterinary Research Source Type: research
The idea involves a controversial type of medical study known as a human challenge trial.
Source: L.A. Times - Health - Category: Consumer Health News Authors: Source Type: news
Soon after its identification, norovirus (NoV) has been indicated as one of the most common causes of outbreaks of acute gastroenteritis (AGE) and sporadic acute diarrhea episodes in subjects of any age. In 2016 the World Health Organization stated that the development of a NoV vaccine should be considered an absolute priority. Unfortunately, the development of an effective NoV vaccine has proven extremely difficult, and only in recent years, some preparations have been tested in humans in advanced clinical trials. In this paper, reasons that justify efforts to develop a NoV vaccine, difficulties encountered during NoV vac...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Gangliosides are carbohydrate-containing sphingolipids that are widely expressed in normal tissues, making most subtypes unsuitable as targets for cancer therapy. However, the disialoganglioside GD2 subtype has limited expression in normal tissues but is overexpressed across a wide range of tumors. Disialoganglioside GD2 can be considered a tumor-associated antigen and well-suited as a target for cancer therapy. Disialoganglioside GD2 is implicated in tumor development and malignant phenotypes through enhanced cell proliferation, motility, migration, adhesion, and invasion, depending on the tumor type. This provides a rati...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
The ethics committee of the All India Institute of Medical Sciences in New Delhi has found discrepancies in the protocol submitted for trials, raising questions on how other sites enrolled for the trials have got approvals from their ethics committees.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
(Natural News) Clamped down by communist control, the Chinese people are being marched toward permanent bodily requirements — their DNA surrendered over to the state and their immune systems sacrificed to and engineered by pharmaceutical companies. In China, there are four major drug manufacturers working on a seasonal covid-19 inoculation — CanSino Biologics, the Wuhan...
Source: - Category: Consumer Health News Source Type: news
(Natural News) During a recent interview with TIME, Melinda Gates, co-chair of the infamous Bill &Melinda Gates Foundation, spelled out the order in which she believes people need to be vaccinated for the Wuhan coronavirus (COVID-19). First in line after health care workers, she divulged, will be black people, which are supposedly more at...
Source: - Category: Consumer Health News Source Type: news
More News: Borrelia | Brain | Encephalitis | Infectious Diseases | Lyme Disease | Mania | Neurology | Psychiatry | Tickborne Diseases | Vaccines